001480870 000__ 05920cam\\22005537a\4500
001480870 001__ 1480870
001480870 003__ OCoLC
001480870 005__ 20231031003312.0
001480870 006__ m\\\\\o\\d\\\\\\\\
001480870 007__ cr\un\nnnunnun
001480870 008__ 230916s2023\\\\si\\\\\\o\\\\\000\0\eng\d
001480870 019__ $$a1397313825
001480870 020__ $$a9789819924042$$q(electronic bk.)
001480870 020__ $$a9819924049$$q(electronic bk.)
001480870 020__ $$z9819924030
001480870 020__ $$z9789819924035
001480870 0247_ $$a10.1007/978-981-99-2404-2$$2doi
001480870 035__ $$aSP(OCoLC)1397574066
001480870 040__ $$aEBLCP$$beng$$cEBLCP$$dYDX$$dGW5XE
001480870 049__ $$aISEA
001480870 050_4 $$aRS192
001480870 08204 $$a615.1$$223/eng/20230927
001480870 24500 $$aAdditive manufacturing in pharmaceuticals /$$cSubham Banerjee, editor.
001480870 260__ $$aSingapore :$$bSpringer,$$c2023.
001480870 300__ $$a1 online resource (378 p.)
001480870 500__ $$aDescription based upon print version of record.
001480870 500__ $$a2.5.2.1 Fast-Dissolving Oral Film
001480870 5050_ $$aIntro -- Preface -- Contents -- Editors and Contributors -- About the Editor -- Contributors -- 1 History and Present Scenario of Additive Manufacturing in Pharmaceuticals -- 1.1 Historical Foundation of AM Technologies for Pharmaceuticals -- 1.2 Overview of AM and Process Considerations for Use in Pharma -- 1.2.1 Stereolithography (SLA) -- 1.2.2 Fusion Deposition Modeling (FDM) -- 1.2.3 Selective Laser Sintering (SLS) -- 1.2.4 Semi Solid Extrusion (SSE) -- 1.2.5 Binder Jet 3D Printing (BJ3DP) -- 1.3 Current State of AM Technologies in Pharmaceutical Practice
001480870 5058_ $$a1.3.1 Personalization, Point of Use, and On Demand Manufacturing -- 1.3.2 Improving Bioavailability for Low Solubility Compounds (e.g., BCS II and IV) -- 1.3.2.1 FDM -- 1.3.2.2 SLS -- 1.3.2.3 SSE -- 1.3.2.4 Inkjet Printing and BJ3DP -- 1.3.3 Modulating Release Kinetics of Dosage Forms -- 1.3.3.1 SLA -- 1.3.3.2 FDM -- 1.3.3.3 SLS -- 1.3.3.4 SSE -- 1.3.3.5 BJ3DP -- 1.3.4 Combining Medications into a Single Dosage Unit ("Polypill") -- 1.3.4.1 SLA -- 1.3.4.2 FDM -- 1.3.4.3 SLS -- 1.3.4.4 SSE -- 1.3.4.5 BJ3DP -- 1.3.5 Orodispersible Dosage Forms -- 1.3.5.1 State of the Art -- 1.3.5.2 FDM
001480870 5058_ $$a1.3.5.3 SLS -- 1.3.5.4 SSE -- 1.3.5.5 BJ3DP -- 1.3.6 Other AM Uses of Note -- 1.4 Conclusions -- References -- 2 Fused Deposition Modeling (FDM) of Pharmaceuticals -- 2.1 Introduction -- 2.2 Process Technology and Principles of Printing -- 2.2.1 Fused Deposition Modeling Equipment -- 2.2.2 The Printing Process -- 2.2.2.1 Mass Flow During Fused Deposition Modeling 3D-Printing -- 2.2.3 Material Processability -- 2.2.3.1 Feedability -- 2.2.3.2 Flowability -- 2.2.3.3 Stability -- 2.2.3.4 Enhancing Printing Performance -- 2.2.4 Alternative Feedstock Materials
001480870 5058_ $$a2.3 Materials Used in Fused Deposition Modeling 3D-Printing -- 2.3.1 Carrier -- 2.3.1.1 Cellulose Derivatives -- 2.3.1.2 Ethylene Vinyl Acetates -- 2.3.1.3 Kollicoat IR -- 2.3.1.4 Polycaprolactone -- 2.3.1.5 Polyethylene Oxide -- 2.3.1.6 Polylactic Acid -- 2.3.1.7 Polymethacrylates -- 2.3.1.8 Polyurethanes -- 2.3.1.9 Polyvinyl Alcohol -- 2.3.1.10 Polyvinyl Pyrrolidone -- 2.3.1.11 Soluplus -- 2.3.2 Active Pharmaceutical Ingredient -- 2.3.3 Processing Aids -- 2.3.3.1 Plasticizer -- 2.3.3.2 Dissolution Modifier -- 2.3.3.3 Inert Filler -- 2.3.3.4 Glidant -- 2.3.3.5 Specialty Excipient
001480870 5058_ $$a2.4 Characterization Techniques -- 2.4.1 Mechanical Resilience -- 2.4.2 Topography -- 2.4.3 Solid State and Degradation -- 2.4.4 Stability -- 2.4.5 Porosity -- 2.4.6 Dissolution Behaviour -- 2.4.7 Distribution Homogeneity -- 2.4.8 Specific Requirements -- 2.5 Pharmaceutical Applications -- 2.5.1 Oral Solid Dosage Forms -- 2.5.1.1 Multi-drug Therapies -- 2.5.1.2 Paediatric Dosage Forms -- 2.5.1.3 Targeting Specific Release -- 2.5.1.4 Amorphous Solid Dispersion -- 2.5.1.5 Complex Oral Dosage Forms -- 2.5.1.6 Print and Fill Technology -- 2.5.2 Transdermal and Transmucosal Films
001480870 506__ $$aAccess limited to authorized users.
001480870 520__ $$aThis book presents the different 3D/4D printing technological applications of Additive Manufacturing (AM) in Pharmaceutical Sciences. The initial chapter provides the historical perspective and current scenario of AM in pharmaceuticals. The book further discusses about different 3D printing platform technologies such as FDM, SLA, SLS, SSE, Ink-jet & binder jet principles & applications in developing advanced drug delivery systems. It also covers the methodology, materials for AM and important parameters associated with these platform technologies. The book highlights the progress and practical applications of 4D-printing technology in healthcare & pharmaceuticals fraternity as well including the essence of bioprinting in pharmaceuticals. Finally, the book reviews the regulatory guidelines, perspectives, and integration of Artificial Intelligence (AI)/Machine learning (ML) in pharmaceutical AM. This book is indeed a valuable resource for students, researchers/scholars, young start-ups/entrepreneurs, and pharmaceutical professionals by providing thorough detailing about AM in Pharmaceuticals.
001480870 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed September 27, 2023).
001480870 650_0 $$aPharmaceutical technology.
001480870 650_0 $$aAdditive manufacturing.
001480870 650_0 $$aDrug delivery systems$$xTechnological innovations.
001480870 655_0 $$aElectronic books.
001480870 7001_ $$aBanerjee, Subham.
001480870 77608 $$iPrint version:$$aBanerjee, Subham$$tAdditive Manufacturing in Pharmaceuticals$$dSingapore : Springer,c2023$$z9789819924035
001480870 852__ $$bebk
001480870 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-99-2404-2$$zOnline Access$$91397441.1
001480870 909CO $$ooai:library.usi.edu:1480870$$pGLOBAL_SET
001480870 980__ $$aBIB
001480870 980__ $$aEBOOK
001480870 982__ $$aEbook
001480870 983__ $$aOnline
001480870 994__ $$a92$$bISE